T he role of sex is being increasingly and importantly acknowledged in the expression of a broad spectrum of cardiac diseases. 
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Before accepting this hypothesis, the data should be considered in the context of the known geometric and physiological differences between male and female hearts. Foremost among these is the fact that hearts from male subjects in general tend to be larger. In human studies, this is true both in absolute terms and also if the data are indexed to body surface area, although Devereux3 has shown that if heart mass is normalized to lean body mass the sex difference is eliminated. This suggests that the difference in heart size is to some extent secondary to body size rather than a genetically determined characteristic and also that men have a relative degree of hypertrophy in the absence of any pathological load. Relevant to the present report are data from the Framingham Study that suggest that with aging, female hearts continue to enlarge, whereas male hearts, although still larger than females, show a slight decline in size. 4 In addition (and probably related), women tend to have higher resting heart rates than men, probably reflecting both decreased blood hemoglobin content and increased adrenergic tone that would translate into a relatively smaller stroke volume and reduced end-diastolic dimension. In fact, to increase cardiac output during submaximal The acute dynamic exercise, healthy women tend to increase cardiac output by increasing end-diastolic volume, whereas men tend to increase ejection fraction. 5 Two alternate approaches to the present data are suggested by this physiology: The first is to view the hearts in this study as isolated organs pumping against fixed resistances. The similar valve areas should theoretically impose equivalent resistances in both the larger male and the smaller female hearts. However, despite the 41% increase in left ventricular mass in male hearts, the female hearts generated similar absolute stroke volumes but with a greater systolic pressure and dP/dt and a smaller end-systolic dimension. The ability to perform in this manner may conceivably have been related to the more favorable ventricular geometry, resulting in lower systolic wall stress in the women.
A second interpretation is to envision distinct chronic adaptations to gradually increasing systolic afterload in men and women, the most salient feature of which is exaggerated hypertrophy in the men. It is not known when aortic stenosis becomes hemodynamically significant either in men or in women, but it is likely that there are many years of increased systolic loading before the patients present. It is also conceivable (though unlikely) that the onset of degenerative aortic stenosis may be at a younger age in men than in women and that the hearts in this study were subjected to different durations of increased afterload. In general, however, healthy men have greater cardiac output and lower heart rates and therefore comparatively larger stroke volumes than women. Thus, as aortic stenosis develops in the two sexes, the systolic load would be greater in the male hearts, leading to an increase in systolic wall stress, exaggerated hypertrophy, ventricular dilation, and earlier ventricular dysfunction.
Having offered these alternate interpretations of the data, in fact there are ample clinical and experimental studies that support the conclusion that intrinsic sexspecific differences in cardiac muscle physiology and biochemistry do exist. For example, male mice have greater mitocondrial respiratory and lysosomal enzyme activities than female mice,6 and female rats have greater myosin ATPase activities and a higher percentage of the V1 myosin isozyme than male rats.7 The myosin isoenzymes and ATPase activities in female hearts are upregulated by estrogen and, to a greater extent, by testosterone. 8 In addition, testosterone causes cardiac muscle hypertrophy and increases inotropy in the absence of an effect on preload or systemic vascular resistance in rats. 8 
